Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole lozenge for oral candidiasis
IRCT20191106045356N16Phase 3Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluconazole in oral candidiasis (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Cotton feeling in the mouth, Loss of taste and 1 more. Started Dec 2022; status: completed.
02
Drugs
fluconazole
03
Conditions
oral candidiasis
Beyond the preview
Go deeper on IRCT20191106045356N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191106045356N16.